Please provide your email address to receive an email when new articles are posted on . 84.8% of patients who followed the protocol completed CT scans without any adverse reaction. 53.3% of patients ...
LIBERTY met all primary/secondary endpoints, with lower 6-day TEAEs/ISRs/hypersensitivity (56.5% vs 91.4%) and systemic AEs ...
A non-exhaustive summary of reported cases of cutaneous reactions caused by a metallic implant is given in Table 5. Although many of the patients were patch test positive to their implanted metals, it ...
1 Department of Microbiology & Immunology, The University of Melbourne, Parkville, Victoria 3010, Australia. An increasing number of HLA associations have been observed with drug-hypersensitivity ...
Hypersensitivity reactions to vaccines occur in 1 in 50,000 to 1 in 100,000 doses. Most are local reactions and allow for the completion of the vaccination series. Systemic reactions are a minority ...
—An analysis of registry data concluded that hypersensitivity reactions in patients with mastocytosis are caused by exposure to certain triggers, including low tryptase levels and stings from certain ...
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma Efficacy of ...
The rate of hypersensitivity reactions (HSRs) to gadolinium-based contrast agents (GBCAs) is 0.4 percent, and premedication can reduce the risk for HSRs in patients with a history of acute or delayed ...
InvestorsHub on MSN
Invivyd reports positive phase 3 LIBERTY results for VYD2311 and plans accelerated approval submission
Invivyd reported statistically significant Phase 3 safety and tolerability results for VYD2311 compared with an mRNA-based ...
Hypersensitivity reactions following platinum-based treatment appear to be more severe than hypersensitivity reactions after taxanes among patients with cancer. Hypersensitivity reactions (HSRs) at an ...
In rare cases, people who receive the two-dose Moderna COVID-19 vaccine may experience a red, itchy patch of skin a few days later at the injection site, a new report finds. They shouldn't panic: This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results